Journal Article

DZNE-2025-00479

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Alpha-Synuclein Demonstrates Varying Binding Affinities With Different Tau Isoforms.

Fischer, A.-L. (First author)DZNE* ; Schmitz, M.DZNE* ; Thom, T.DZNE* ; Zafar, S.DZNE* ; Younas, N.DZNE* ; da Silva Correia, S.DZNE* ; Silva-Correia, S.DZNE* ; Canaslan, S.DZNE* ; Zerr, I. (Last author)DZNE*

2025
Wiley-Blackwell Oxford

This record in other databases:    

Please use a persistent id in citations: doi:10.1111/jnc.70053

Abstract: The hallmark of various neurodegenerative diseases is the accumulation and aggregation of amyloidogenic proteins, such as amyloid-beta (Aβ) and tau in Alzheimer's disease (AD) and alpha-synuclein (aSyn) in synucleinopathies. Many neurodegenerative diseases express mixed pathology. For instance, Lewy bodies are reported in tauopathies and neurofibrillary tau-tangles are detected in synucleinopathies, suggesting a potential co-existence or crosstalk of misfolded aSyn and tau. In the present study, we investigated the binding characteristics of monomeric aSyn with different tau isoforms by using surface plasmon resonance (SPR) spectroscopy allowing monitoring direct protein-protein interactions and their potential co-localization using SH-SY5Y cells. The calculation of the binding parameters (association and dissociation rate constants) indicated the strongest binding affinity between aSyn and tau isoform 1N3R followed by tau 2N3R and tau 2N4R. Co-localization studies in SH-SY5Y cells, treated with aSyn and all six tau isoforms revealed an intracellular co-localization of aSyn with different isoforms of tau. Subcellular fractionation confirmed the cellular uptake and colocalization of tau and aSyn in the same compartment, showing their expression in membrane, nuclear, and cytoskeletal fractions. Understanding the intricate interplay between aSyn and tau is crucial for unraveling the pathophysiology of PD, AD, and related neurodegenerative disorders, ultimately paving the way for the development of effective treatments targeting this interaction. In conclusion, our data indicate that aSyn and tau are direct interaction partners with varying binding affinities depending on the tau isoform. This interaction may be significant for understanding the pathophysiology of dementia with mixed pathologies.

Keyword(s): Humans (MeSH) ; tau Proteins: metabolism (MeSH) ; alpha-Synuclein: metabolism (MeSH) ; Protein Isoforms: metabolism (MeSH) ; Protein Binding: physiology (MeSH) ; Cell Line, Tumor (MeSH) ; Surface Plasmon Resonance (MeSH) ; Alzheimer's disease ; Parkinson's disease ; alpha‐synuclein ; interaction ; synucleinopathies ; tau ; tauopathies ; tau Proteins ; alpha-Synuclein ; Protein Isoforms

---

Contributing Institute(s):

1. Translational Studies and Biomarker (AG Zerr)

Research Program(s):

1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2025

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---